Vinal R. Patel

Representative Experience

• Represented General Catalyst and Health Assurance Transformation, LLC (HATCo) on the proposed combination of Summa Health with HATCo.
• Represented Boston Medical Center, one of the oldest and most renowned nonprofit hospital systems in the US (BMC), in its successful acquisition of two Boston-area safety net hospitals, Good Samaritan and St. Elizabeth’s, from bankrupt Steward Healthcare System LLC. The transaction was approved by the US Bankruptcy Court for the Southern District of Texas and closed on October 1, 2024. *
• Represented a private equity company and its portfolio company, a global provider of connected healthcare operations software and services, in its acquisition of a healthcare technology company supplying patient satisfaction, reputation management and revenue growth solutions. *
• Represented a private equity-backed independent insurance broker in its $13 billion+ sale to an insurance, risk management, and consulting company. *
• Advised a national behavioral health provider in connection with parallel investigations by the DOJ and SEC concerning admissions, billing practices, and patient treatment protocols. Conducted internal reviews and coordinated responses to federal subpoenas and media-reported allegations. Provided strategic regulatory counsel to support the client’s compliance posture and stakeholder communications during a high-profile inquiry. *
• Represented a private equity company in its investment of a health care technology company offering a proprietary pharmaceutical revenue leakage solution aimed at helping pharmaceutical manufacturers’ patient assistance programs reach their intended recipients to support access and affordability.
• Represented a private equity company in its $632 million acquisition of a direct-to-consumer insurance services company in a corporate carve-out from a leading global advisory, brokering and solutions company. *
• Represented a private equity-backed provider of oncology services in its $1 billion+ sale to a global manufacturer and distributor of medical and laboratory products. *
• Represented a private equity company and its portfolio company, a leading provider of women’s health services including fertility services, obstetrics/gynecology (OB/GYN), mammography, surgery, ultrasound and imaging, and laboratory services, in multiple internal restructuring, acquisition, advising, and sale matters. *
• Represented a leading pharmaceutical manufacturer in its investigation of and litigation against compounding pharmacies related to alleged FDA violations. *
• Represented a private equity company in its acquisition of a leading healthcare technology platform for the diagnosis and treatment of children on the autism spectrum. *
• Represented a publicly-traded genetic testing company with approximately $1.5 billion in funded debt obligations and certain of its affiliates in their Chapter 11 cases and prior to the commencement of Chapter 11, in its go-forward sale process with a significant majority of its secured noteholders. *